Alzheimer's disease: Role of aging in pathogenesis

Annals of the New York Academy of Sciences

Volumn 959, Issue , 2002, Pages 384-395

  Harman, Denham ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Aging; Alzheimer's disease; Dementia pugilistica; Free radicals; Mutations

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CALCIUM ION; ESTROGEN; HYDROGEN PEROXIDE; INDOMETACIN; SELEGILINE; SUPEROXIDE;

AGING; ALZHEIMER DISEASE; CALCIUM TRANSPORT; CELL LOSS; CLINICAL FEATURE; CONFERENCE PAPER; DEMENTIA; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; MICROGLIA; MITOCHONDRION; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; SENILE PLAQUE;

EID: 0036240716     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02109.x     Document Type: Conference Paper

References (93)

1. Alzheimer's disease
2. Advances in Alzheimer's disease
3. Systemic manifestations of Alzheimer's disease
4. Free radical theory of aging: Alzheimer's disease pathogenesis
5. Risky apolipoprotein in brain
6. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
7. A familial Alzheimer's disease locus on chromosome 1
8. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
9. Alzheimer disease: Basic and clinical advances
10. Neuritic pathology and dementia in Alzheimer's disease
11. Ultrastructural alterations in senile dementia
12. Structural basis of the cognitive alterations
13. Amyloidogenicity of βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation
14. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome
15. Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease
16. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease
17. Amyloid and Alzheimer's disease
18. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
19. Translating cell biology into therapeutic advances in Alzheimer's disease
20. Mechanisms of neuronal degeneration in Alzheimer's disease
21. Alzheimer's disease: The amyloid cascade hypothesis
22. New clues to Alzheimer's disease: Unraveling the roles of amyloid and tau
23. Alzheimer's disease: Genotypes, phenotypes, and treatments
24. The pathogenesis of senile plaques
25. Aging: Phenomena and theories
26. Aging: Prospects for further increases in the functional life span
27. Aging: A theory based on free radical and radiation chemistry
28. Free radical theory of aging: History
29. Free radical theory of aging: Increasing the average life expectancy at birth and the maximum life span
30. Hydrogen peroxide release by mitochondria increases during aging
31. Mitochondrial DNA mutations and age
32. Oxidative stress up-regulates IL-8 and TNF-α synthesis by human dendritic cells
33. Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration
34. Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer's disease
35. Revolution in mitochondrial medicine
36. Mitochondrial involvement in Alzheimer's disease
37. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients
38. The genetics of Alzheimer's disease: Current status and future prospects
39. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer's disease
40. Amyloid, the presenilins, and Alzheimer's disease
41. The amyloid precursor protein of Alzheimer's disease is found on the surface of static, but not actively motile portions of neurites
42. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin
43. The influence of endoproteolytic processing of familial Alzheimer's disease presenilin 2 on Aβ42 amyloid peptide formation
44. Autophagy, micro-autophagy, and crinophagy as mechanisms for protein degradation
45. The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation
46. Structure of the calcium pump from sarcoplasmic reticulum at 8-Å resolution
47. +-ATPase in the open conformation
48. 2+-ATPases
49. 2+ homeostasis
50. Inositol phosphates and cell signalling
51. Inhibition of the skeletal muscle ryanodine receptor calcium channel by nitric oxide
52. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation
53. 2+-ATPase through intramembrane interactions
54. 2+-ATPase by phospholamban
55. Sites on the cytoplasmic region of phospolamban involved in interaction with calcium-activated ATPase of the sarcoplasmic reticulum
56. 2+-ATPase
57. 2+-ATPase
58. 2+-ATPase
59. Alteration of acylphosphatase levels in familial Alzheimer's disease fibroblasts with presenilin gene mutations
60. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis
61. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function
62. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: Central roles of superoxide production and caspase activation
63. Oxidants in mitochondria: From physiology to diseases
64. Down's syndrome and Alzheimer's disease: A review
65. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease
66. Aging and Alzheimer's disease in people with Down's syndrome
67. Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: A model of Down's syndrome
68. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
69. The association between head trauma and Alzheimer's disease
70. The occult aftermath of boxing
71. Neurological sequelae of boxing
72. βA4 amyloid protein deposition in brain after head trauma
73. The cerebral vasculature in dementia pugilistica
74. Hydrogen peroxide mediates amyloid β protein toxicity
75. Alzheimer's disease: A hypothesis on pathogenesis
76. Prospects for pharmacological intervention in Alzheimer's disease
77. Aging: Minimizing free radical damage
78. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
79. Neuroprotection by the metabolic antioxidant α-lipoic acid
80. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters
81. Propofol hemisuccinate protects neuronal cells from oxidative injury
82. The elusive function of metallothioneins
83. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF)
84. NADH-CoQ reductase deficient myopathy: Successful treatment with riboflavin
85. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle
86. 10
87. Clinical trial of indomethacin in Alzheimer's disease
88. Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study
89. Inflammation and Alzheimer's disease pathogenesis
90. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
91. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
92. A substrate-based difluoro ketone selectively inhibits Alzheimer's γ-secretase activity
93. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation